Skip to main content

RA CAPITAL MANAGEMENT, L.P.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1346824 BOSTON, MA

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,360,000
+$16,320,000 QoQ
Shares Held
8,000,000
0.0% QoQ
Ownership
6.50%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2
of 147 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. CCCC ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,360,000 8,000,000
2026-06-30 $53,161,860 11,383,696
2026-03-31 $21,040,000 8,000,000
2025-12-31 $15,280,000 8,000,000
2025-10-17 $22,375,776 9,441,256
2024-12-31 $17,560,800 4,878,000
2024-09-30 $27,804,600 4,878,000
2024-06-30 $22,536,360 4,878,000
2024-03-31 $39,853,260 4,878,000
2023-12-31 $27,560,700 4,878,000
2021-12-31 $44,357,721 1,377,569
2021-09-30 $61,549,782 1,377,569
2021-06-30 $52,127,210 1,377,569
2021-03-31 $50,956,277 1,377,569
2020-12-31 $45,638,860 1,377,569